Patou Gary
- SEC CIK
- 0001283535
In the past year, 1 open-market sale filing worth $70.3K and no purchases.
Current role at each company
- XENE Xenon Pharmaceuticals Inc.Directoras of Jun 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $70.3K
- 1 filing
- Net
- −$70.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Patou Gary as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 (view filing) | Jun 5 | 3 days | Patou GaryDirector | SSale | −1.32K | $53.14 | −$70.3K | −5.0%24.9K after | 10b5-1 |
| Nov 22, 2024 (view filing) | Nov 22 | Same day | Patou GaryDirector | SSale | −4.89K | $41.08 | −$200.9K | −17.2%23.6K after | 2 lots |
| Dec 15, 2023 (view filing) | Dec 13 | 2 days | Patou GaryDirector | SSale | −11.4K | $39.29 | −$447.1K | −32.6%23.6K after | From original3 lots |
| Dec 15, 2023 (view filing) | Dec 14 | 1 day | Patou GaryDirector | SSale | −7.60K | $41.05 | −$311.9K | −60.8%4.90K after | Amended |
| Nov 28, 2022 (view filing) | Nov 23-25 | 5 days | Patou GaryDirector | SSale | −3.99K | $34.55 | −$138.0K | −14.5%23.6K after | 2 lots |